Skip to main content
. 2018 Sep 7;8:281. doi: 10.3389/fcimb.2018.00281

Table 7.

F. prausnitzii, its phylogroups and A. muciniphila abundances in inflammatory bowel disease by medication at sampling.

Diagnostics§ n F. prausnitzii* P-value Phylogroup I* P-value Phylogroup II* P-value A. muciniphila P-value
UC
No treatment 11 4.81 ± 0.72 1.94 ± 1.35 2.74 ± 1.13 3.10 ± 1.11
Mesalazine 3 4.87 ± 0.40 0.783 2.30 ± 0.97 0.578 3.20 ± 1.01 0.639 3.53 ± 1.82 0.387
Mod. Immsup 4 4.95 ± 0.61 2.97 ± 0.33 3.18 ± 1.54 3.06 ± 0.51
Anti-TNF 3 4.35 ± 0.96 1.53 ± 1.85 2.37 ± 1.03 2.10 ± 1.52
CD
No treatment 10 4.30 ± 1.51 1.04 ± 1.96 1.67 ± 1.61 2.69 ± 1.08
Mesalazine 3 5.00 ± 0.41 0.537 1.30 ± 1.67 0.975 2.24 ± 1.89 0.719 3.90 ± 2.20 0.125
Mod. Immsup 10 3.84 ± 1.21 0.99 ± 1.50 1.15 ± 1.09 3.72 ± 0.97
Anti-TNF 6 4.31 ± 1.68 1.42 ± 1.76 1.60 ± 1.42 2.72 ± 1.78
*

Median (log10 16S rRNA gene copies/million bacterial 16S rRNA gene copies) ± standard deviations.

§

UC, ulcerative colitis; CD, Crohn's disease; Mod. Immsup, moderate immunosuppresants; Anti-TNF, Anti-tumor necrosis factor.